HWKN vs. AMPH
Compare and contrast key facts about Hawkins, Inc. (HWKN) and Amphastar Pharmaceuticals, Inc. (AMPH).
Performance
HWKN vs. AMPH - Performance Comparison
Loading graphics...
HWKN vs. AMPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
HWKN Hawkins, Inc. | 8.27% | 16.45% | 75.46% | 84.66% | -0.81% | 53.05% | 16.44% | 14.35% | 19.23% | -33.43% |
AMPH Amphastar Pharmaceuticals, Inc. | -26.85% | -27.88% | -39.97% | 120.74% | 20.31% | 15.81% | 4.25% | -3.07% | 3.43% | 4.45% |
Fundamentals
HWKN:
$3.20B
AMPH:
$923.94M
HWKN:
$3.96
AMPH:
$2.06
HWKN:
38.83
AMPH:
9.52
HWKN:
1.92
AMPH:
0.50
HWKN:
3.01
AMPH:
1.30
HWKN:
6.17
AMPH:
1.17
HWKN:
$1.06B
AMPH:
$719.89M
HWKN:
$243.06M
AMPH:
$356.06M
HWKN:
$159.57M
AMPH:
$191.74M
Returns By Period
In the year-to-date period, HWKN achieves a 8.27% return, which is significantly higher than AMPH's -26.85% return. Over the past 10 years, HWKN has outperformed AMPH with an annualized return of 25.40%, while AMPH has yielded a comparatively lower 4.43% annualized return.
HWKN
- 1D
- 1.31%
- 1M
- 3.02%
- YTD
- 8.27%
- 6M
- -15.70%
- 1Y
- 45.78%
- 3Y*
- 53.10%
- 5Y*
- 36.65%
- 10Y*
- 25.40%
AMPH
- 1D
- 1.93%
- 1M
- -3.16%
- YTD
- -26.85%
- 6M
- -26.49%
- 1Y
- -32.42%
- 3Y*
- -19.46%
- 5Y*
- 1.61%
- 10Y*
- 4.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HWKN vs. AMPH — Risk / Return Rank
HWKN
AMPH
HWKN vs. AMPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Hawkins, Inc. (HWKN) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HWKN | AMPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.21 | -0.66 | +1.87 |
Sortino ratioReturn per unit of downside risk | 1.75 | -0.73 | +2.48 |
Omega ratioGain probability vs. loss probability | 1.23 | 0.90 | +0.33 |
Calmar ratioReturn relative to maximum drawdown | 1.31 | -0.76 | +2.07 |
Martin ratioReturn relative to average drawdown | 2.92 | -1.67 | +4.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| HWKN | AMPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.21 | -0.66 | +1.87 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.01 | 0.04 | +0.98 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.68 | 0.11 | +0.57 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.39 | 0.17 | +0.23 |
Correlation
The correlation between HWKN and AMPH is 0.27, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
HWKN vs. AMPH - Dividend Comparison
HWKN's dividend yield for the trailing twelve months is around 0.49%, while AMPH has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HWKN Hawkins, Inc. | 0.49% | 0.52% | 0.55% | 0.88% | 1.45% | 1.28% | 1.78% | 2.01% | 2.17% | 2.44% | 1.52% | 2.18% |
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
HWKN vs. AMPH - Drawdown Comparison
The maximum HWKN drawdown since its inception was -44.76%, smaller than the maximum AMPH drawdown of -72.04%. Use the drawdown chart below to compare losses from any high point for HWKN and AMPH.
Loading graphics...
Drawdown Indicators
| HWKN | AMPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.76% | -72.04% | +27.28% |
Max Drawdown (1Y)Largest decline over 1 year | -34.79% | -41.01% | +6.22% |
Max Drawdown (5Y)Largest decline over 5 years | -34.79% | -72.04% | +37.25% |
Max Drawdown (10Y)Largest decline over 10 years | -44.76% | -72.04% | +27.28% |
Current DrawdownCurrent decline from peak | -16.53% | -69.86% | +53.33% |
Average DrawdownAverage peak-to-trough decline | -15.73% | -23.32% | +7.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.56% | 18.61% | -3.05% |
Volatility
HWKN vs. AMPH - Volatility Comparison
Hawkins, Inc. (HWKN) has a higher volatility of 13.50% compared to Amphastar Pharmaceuticals, Inc. (AMPH) at 12.83%. This indicates that HWKN's price experiences larger fluctuations and is considered to be riskier than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| HWKN | AMPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.50% | 12.83% | +0.67% |
Volatility (6M)Calculated over the trailing 6-month period | 29.94% | 38.92% | -8.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.02% | 49.46% | -11.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.37% | 43.53% | -7.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.48% | 42.12% | -4.64% |
Financials
HWKN vs. AMPH - Financials Comparison
This section allows you to compare key financial metrics between Hawkins, Inc. and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HWKN vs. AMPH - Profitability Comparison
HWKN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Hawkins, Inc. reported a gross profit of 50.81M and revenue of 244.08M. Therefore, the gross margin over that period was 20.8%.
AMPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported a gross profit of 85.67M and revenue of 183.11M. Therefore, the gross margin over that period was 46.8%.
HWKN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Hawkins, Inc. reported an operating income of 22.56M and revenue of 244.08M, resulting in an operating margin of 9.2%.
AMPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported an operating income of 35.61M and revenue of 183.11M, resulting in an operating margin of 19.5%.
HWKN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Hawkins, Inc. reported a net income of 14.31M and revenue of 244.08M, resulting in a net margin of 5.9%.
AMPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Amphastar Pharmaceuticals, Inc. reported a net income of 24.43M and revenue of 183.11M, resulting in a net margin of 13.3%.